Published ahead of print on April 28, 2005, doi:10.1164/rccm.200408-1041OC
Am. J. Respir. Crit. Care Med., Volume 172, Number 6, September 2005, 704-712
A more recent version of this article appeared on September 15, 2005
Submitted on August 12, 2004
Accepted on April 25, 2005
Glucocorticoid Receptor Nuclear Translocation in Airway Cells Following Inhaled Combination Therapy
Omar S Usmani1, Kazuhiro Ito1, Kittipong Maneechotesuwan1, Misako Ito1, Malcolm Johnson1, Peter J Barnes1, and Ian M Adcock1*
1 Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK
* To whom correspondence should be addressed. E-mail: ian.adcock{at}imperial.ac.uk.
Clinical evidence is accumulating for the efficacy of adding inhaled long-acting 2-agonists (LABAs) to corticosteroids in asthma. Corticosteroids bind to cytoplasmic glucocorticoid receptors (GRs), which then translocate to the nucleus where they regulate gene expression. Here we report the first evidence in vivo of an interaction between inhaled LABA and corticosteroid on GR nuclear translocation in human airway cells using immunocytochemistry. We initially demonstrated significant GR activation 60 minutes following inhalation of 800µg beclomethasone dipropionate in six healthy subjects. Subsequently, we determined the effects of salmeterol and fluticasone propionate (FP) in seven steroid-naive asthmatics. We observed dose-dependent GR activation with FP 100µg and 500µg doses, and to a lesser extent with salmeterol 50µg alone. However, combination therapy with FP 100µg and salmeterol augmented the action of FP on GR nuclear localization. In vitro salmeterol enhanced FP effects on GR nuclear translocation in epithelial and macrophage-like airway cell lines. In addition, salmeterol in combination with FP, enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated-protein kinase phosphatase-1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction. Together, our data confirm that GR nuclear translocation may underlie the complementary interactions between LABAs and corticosteroids, although the precise signal transduction mechanisms remain to be determined.
Key words: Transcription Factors, Human, Lung, Asthma, Therapy
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Wilson, P. Shen, C. F. Rider, S. L. Traves, D. Proud, R. Newton, and M. A. Giembycz
Selective Prostacyclin Receptor Agonism Augments Glucocorticoid-Induced Gene Expression in Human Bronchial Epithelial Cells
J. Immunol.,
November 15, 2009;
183(10):
6788 - 6799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Black, B. G. G. Oliver, and M. Roth
Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting {beta}-Agonists
Chest,
October 1, 2009;
136(4):
1095 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papi, G. Caramori, I. M. Adcock, and P. J. Barnes
Rescue Treatment in Asthma: More Than As-Needed Bronchodilation
Chest,
June 1, 2009;
135(6):
1628 - 1633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. O'Byrne, I. P. Naya, A. Kallen, D. S. Postma, and P. J. Barnes
Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled {beta}2-Agonists in Achieving Asthma Control
Chest,
December 1, 2008;
134(6):
1192 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Greening, D. Stempel, E. D. Bateman, and J. C. Virchow
Managing asthma patients: which outcomes matter?
Eur. Respir. Rev.,
June 1, 2008;
17(108):
53 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, O. A. Minai, and Z. Mosenifar
Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
506 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kaur, J. E. Chivers, M. A. Giembycz, and R. Newton
Long-Acting 2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells
Mol. Pharmacol.,
January 1, 2008;
73(1):
203 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa, R. McGhan, D. Niewoehner, and B. Make
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
535 - 542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Salter, K. Biggadike, J. L. Matthews, M. R. West, M. V. Haase, S. N. Farrow, I. J. Uings, and D. W. Gray
Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L660 - L667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zhang, Q. A. Truong-Tran, B. Tancowny, K. E. Harris, and R. P. Schleimer
Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins
J. Immunol.,
July 1, 2007;
179(1):
578 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Edwards, J. Haas, R. A. Panettieri Jr., M. Johnson, and S. L. Johnston
Corticosteroids and beta2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements
J. Biol. Chem.,
May 25, 2007;
282(21):
15366 - 15375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Solway and C. G. Irvin
Airway Smooth Muscle as a Target for Asthma Therapy
N. Engl. J. Med.,
March 29, 2007;
356(13):
1367 - 1369.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Scientific rationale for using a single inhaler for asthma control
Eur. Respir. J.,
March 1, 2007;
29(3):
587 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jaradat, C. Stapleton, S. L. Tilley, D. Dixon, C. J. Erikson, J. G. McCaskill, H. S. Kang, M. Angers, G. Liao, J. Collins, et al.
Modulatory Role for Retinoid-related Orphan Receptor {alpha} in Allergen-induced Lung Inflammation
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1299 - 1309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil
Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD.
Chest,
September 1, 2006;
130(3):
647 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Sin and S. F. P. Man
Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
September 1, 2006;
3(7):
624 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
698 - 706.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, S. Yamamura, S. Essilfie-Quaye, B. Cosio, M. Ito, P. J. Barnes, and I. M. Adcock
Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}B suppression
J. Exp. Med.,
January 23, 2006;
203(1):
7 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Ind
Bigger May Be Better: Targeted {beta}2-Agonist Therapy
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
656 - 657.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|